Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio 45267, USA.
J Pharm Sci. 2012 Jul;101(7):2353-63. doi: 10.1002/jps.23127. Epub 2012 Mar 30.
Previous magnetic resonance imaging (MRI) studies to investigate the routes of penetration and barriers in ocular delivery have provided insights into the mechanisms of transscleral and intraocular drug delivery. The objective of the present study was to investigate ocular penetration and clearance after subconjunctival and intravitreal injections using a contrast agent at concentrations higher than those in the previous studies. This high concentration approach was hypothesized to allow the visualization of the contrast agent in the eye that could not be achieved previously. Subconjunctival and intravitreal injections of contrast agent Magnevist, a model hydrophililc probe, were performed in rabbits, and the distribution and clearance of the probe after the injections were examined by MRI. After subconjunctival injection in vivo, significant contrast agent penetration into the anterior chamber was observed but not into the vitreous. A clearance pathway of the hydrophilic probe from the subconjunctival depot to the regions near the periocular fat behind the eye was found. After intravitreal injection in vivo, the contrast agent was observed in the anterior chamber, optic nerve, and tissues surrounding the eye during clearance. MRI continues to provide insights into the transport barriers and clearance pathways of hydrophilic molecules in ocular delivery.
先前的磁共振成像(MRI)研究旨在探讨眼部递药的穿透途径和屏障,为了解透巩膜和眼内药物递送的机制提供了深入的认识。本研究的目的是在使用高于先前研究浓度的造影剂进行下结膜和玻璃体内注射后,研究眼部穿透和清除情况。该高浓度方法假设可以观察到以前无法实现的眼部造影剂。向兔眼进行下结膜和玻璃体内注射造影剂马根维显(Magnevist),一种模型亲水性探针,通过 MRI 检查注射后探针的分布和清除情况。在体内进行下结膜注射后,观察到显著的造影剂穿透到前房,但没有穿透到玻璃体。发现了一种亲水探针从下结膜储库到眼后眶周脂肪附近区域的清除途径。在体内进行玻璃体内注射后,在清除过程中观察到造影剂在前房、视神经和眼周围组织中。MRI 继续为眼部递药中亲水分子的转运屏障和清除途径提供深入的认识。